Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,853 JPY | +5.32% | +5.72% | 0.00% |
05:59am | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
05:55am | Genmab, Pfizer Win US FDA Approval for Cervical Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.04B | |
+10.04% | 323B | |
+14.96% | 76.06B | |
-6.58% | 67.53B | |
+3.82% | 31.21B | |
+21.80% | 23.54B | |
+11.39% | 14.15B | |
+13.31% | 10.19B | |
+18.52% | 9.07B | |
-7.71% | 6.59B |
- Stock Market
- Equities
- 141A Stock
- News Trial Holdings Inc.
- ClearPoint Neuro Says Partner AviadoBio Treats First Person in Trial of AVB-101 for Frontotemporal Dementia